指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

确定性感染源控制后复杂性腹腔感染抗菌治疗疗程:东部创伤外科协会系统评价、Meta分析与实践管理指南

Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma.
指南 / 共识 · J Trauma Acute Care Surg · 2023-06-15
一句话结论东部创伤外科协会(EAST)推荐:成人复杂性腹腔感染在确定性感染源控制后,抗菌治疗采用短疗程(≤4天)而非长疗程(≥8天)。

本指南由东部创伤外科协会(EAST)工作组制定,系统评价并Meta分析了16项比较短疗程与长疗程抗菌治疗的研究,对象为已行确定性感染源控制的成人复杂性腹腔感染(cIAI)患者。短疗程为1剂至≤10天(平均4天),长疗程为>1天至28天(平均8天)。短疗程与长疗程在死亡率(OR 0.90,95%CI 0.56-1.44)、手术部位感染率(OR 0.88,95%CI 0.56-1.38)、持续性/复发性脓肿(OR 0.76,95%CI 0.45-1.29)、非计划干预(OR 0.53,95%CI 0.12-2.26)、住院时间(均数差 -2.62天,CI -7.08至1.83天)及再入院(OR 0.92,95%CI 0.50-1.69)方面均无差异。证据质量评定为极低。工作组据此推荐短疗程(4天或更短)而非长疗程(8天或更长)。

要点

  • EAST推荐:成人cIAI在确定性感染源控制后,抗菌治疗采用短疗程(4天或更短)而非长疗程(8天或更长)。
  • 短疗程范围为1剂至≤10天(平均4天),长疗程范围为>1天至28天(平均8天)。
  • 短疗程与长疗程死亡率无差异(OR 0.90,95%CI 0.56-1.44),手术部位感染率无差异(OR 0.88,95%CI 0.56-1.38)。
  • 持续性/复发性脓肿(OR 0.76,95%CI 0.45-1.29)、非计划干预(OR 0.53,95%CI 0.12-2.26)、再入院(OR 0.92,95%CI 0.50-1.69)均无差异。
  • 住院时间均数差 -2.62天(CI -7.08至1.83天),证据质量评定为极低(Level III)。

适用人群与场景

  • 已行确定性感染源控制的成人复杂性腹腔感染(cIAI)患者。
  • 仅纳入比较短疗程与长疗程抗菌治疗方案的研究。

诊断标准与关键阈值

  • 短疗程定义为1剂至≤10天(平均4天),长疗程定义为>1天至28天(平均8天)。
  • 短疗程相较于长疗程的非劣效性被定义为支持短疗程潜在推荐指征的指标。

处置流程与药物剂量

  • EAST工作组推荐:成人cIAI患者在确定性感染源控制后,采用短疗程(4天或更短)而非长疗程(8天或更长)抗菌治疗。

研究设计与关键结果

  • 系统评价与Meta分析纳入16项研究,比较短疗程与长疗程抗菌治疗在已行确定性感染源控制的成人cIAI患者中的结局。
  • 死亡率:短疗程 vs 长疗程 OR 0.90(95%CI 0.56-1.44),无差异。
  • 手术部位感染率:OR 0.88(95%CI 0.56-1.38),无差异。
  • 持续性/复发性脓肿:OR 0.76(95%CI 0.45-1.29),无差异。
  • 非计划干预:OR 0.53(95%CI 0.12-2.26),无差异。
  • 住院时间:均数差 -2.62天(CI -7.08至1.83天),无差异。
  • 再入院:OR 0.92(95%CI 0.50-1.69),无差异。
  • 证据质量评定为极低。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析;证据等级:Level III。
  • 采用GRADE方法评估证据质量并制定推荐;证据质量评定为极低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于已行确定性感染源控制的成人cIAI患者,EAST推荐抗菌治疗采用短疗程(4天或更短)而非长疗程(8天或更长)。

指南或共识出处

  • 东部创伤外科协会(EAST)实践管理指南:确定性感染源控制后复杂性腹腔感染抗菌治疗疗程(J Trauma Acute Care Surg)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Recent studies have evaluated outcomes associated with duration of antimicrobial treatment for complicated intra-abdominal infections (cIAI). The goal of this guideline was to help clinicians better define appropriate antimicrobial duration in patients who have undergone definitive source control for cIAI.

METHODS: A working group of Eastern Association for the Surgery of Trauma (EAST) performed a systematic review and meta-analyses of the available data pertaining to the duration of antibiotics after definitive source control of cIAI in adult patients. Only studies that compared patients treated with short vs. long duration antibiotic regimens were included. The critical outcomes of interest were selected by the group. Noninferiority of short compared with long duration of antimicrobial treatment was defined as an indicator for a potential recommendation in favor of shorter antibiotics course. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of the evidence and to formulate recommendations.

RESULTS: Sixteen studies were included. The short duration ranged from 1 dose to ≤10 days, with an average of 4 days, and the long duration ranged >1 day to 28 days, with an average of 8 days. There were no differences between short and long duration of antibiotics in terms of mortality (odds ratio [OR], 0.90; 95% confidence interval [CI], 0.56-1.44), rate of surgical site infection (OR, 0.88; 95% CI, 0.56-1.38); persistent/recurrent abscess (OR, 0.76; 95% CI, 0.45-1.29); unplanned interventions (OR, 0.53; 95% CI, 0.12-2.26); hospital length of stay (mean difference, -2.62 days; CI, -7.08 to 1.83 days); or readmissions (OR, 0.92; 95% CI, 0.50-1.69). The level of evidence was assessed as very low.

CONCLUSION: The group made a recommendation for shorter (four or less days) versus longer duration (eight or more days) of antimicrobial treatment in adult patients with cIAIs who had definitive source control.

LEVEL OF EVIDENCE: Systematic Review and Meta-Analysis; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Ra JH, Rattan R, Patel NJ, et al. Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2023. PMID: 37316989. doi:10.1097/TA.0000000000003998

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。